Compare · LFST vs OPCH
LFST vs OPCH
Side-by-side comparison of LifeStance Health Group Inc. (LFST) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LFST and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $3.21B, about 1.1x LFST ($2.85B).
- Over the past year, LFST is up 34.2% and OPCH is down 38.9% - LFST leads by 73.1 points.
- OPCH has been more active in the news (11 items in the past 4 weeks vs 7 for LFST).
- LFST has more recent analyst coverage (16 ratings vs 14 for OPCH).
- Company
- LifeStance Health Group Inc.
- Option Care Health Inc.
- Price
- $7.38+0.41%
- $20.45-3.99%
- Market cap
- $2.85B
- $3.21B
- 1M return
- +14.77%
- -26.32%
- 1Y return
- +34.18%
- -38.88%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 7
- 11
- Recent ratings
- 16
- 14
LifeStance Health Group Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest LFST
- Amendment: SEC Form SCHEDULE 13G/A filed by LifeStance Health Group Inc.
- LifeStance to Present at Upcoming Investor Conferences
- Director Bessler Robert sold $492,400 worth of shares (69,899 units at $7.04) (SEC Form 4)
- Director Bessler Robert sold $35,758 worth of shares (5,101 units at $7.01) (SEC Form 4)
- SEC Form DEFA14A filed by LifeStance Health Group Inc.
- SEC Form DEF 14A filed by LifeStance Health Group Inc.
- LifeStance to Host First Quarter 2026 Earnings Conference Call on May 7, 2026
- LifeStance Publishes Outcomes Data Validating the Benefit of Mental Health Treatment at Scale
- SEC Form 4 filed by Pardo Ryan
- SEC Form 4 filed by Mcgroarty Ryan
Latest OPCH
- Amendment: SEC Form SCHEDULE 13G/A filed by Option Care Health Inc.
- Director Kraemer Harry M Jansen Jr bought $783,773 worth of shares (36,610 units at $21.41), increasing direct ownership by 9% to 450,000 units (SEC Form 4)
- Option Care Health Inc. filed SEC Form 8-K: Leadership Update
- Chief Financial Officer Sethna Meenal bought $327,075 worth of shares (16,225 units at $20.16), increasing direct ownership by 20% to 98,337 units (SEC Form 4)
- Chief Executive Officer Rademacher John Charles bought $264,706 worth of shares (12,500 units at $21.18), increasing direct ownership by 2% to 695,152 units (SEC Form 4)
- Option Care Health to Participate in the Bank of America Health Care Conference
- Option Care Health downgraded by BofA Securities with a new price target
- SEC Form 10-Q filed by Option Care Health Inc.
- Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2026
- Option Care Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits